Akèy › Adenokasinom Ezofajyen › Delaware › Newark
Etid klinik pou Adenokasinom Ezofajyen nan Newark, DE
3 etid pou Adenokasinom Ezofajyen ap chèche patisipan nan sit nan ak bò kote Newark (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Ap rekriteFaz 2/3
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Ap rekriteFaz 3
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
- Christiana Care Health System-Christiana Hospital, Newark
- ak 1 plis
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Ap rekriteFaz 3
- Research Site, Newark
Etid Adenokasinom Ezofajyen nan lòt vil
- New York City, NY18 etid
- Boston, MA13 etid
- Houston, TX12 etid
- Nashville, TN11 etid
- Arlington, VA11 etid
- Durham, NC10 etid
- Jacksonville, FL9 etid
- Baldwin Park, CA9 etid
- Rochester, MN9 etid
- St. Louis, MO9 etid
- Queens, NY9 etid
- Los Angeles, CA9 etid
Lòt etid nan Newark
- Kansè Poumon ki pa ti selil16 etid
- Kansè pwostat10 etid
- Kansè poumon9 etid
- Kansè kolorektal9 etid
- Kansè nan tete8 etid
- Kansè Metastatik7 etid
- Kansè pankreyas6 etid
- Kansè (tout kalite)6 etid
- Kansè ovè5 etid
- Kansè lestomak4 etid
- Kansè vejik4 etid
- Melanom4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.